The expanding world of diabetes in this month's JCTE  by Olson, Darin E.
The expanding world of diabetes in this month’s JCTE
Many endocrinologists thrive on the expansive nature of endo-
crine disease. However, sometimes it feels like clinical endocrinology
is dominated by diabetes. Understandably, since diabetes is argu-
ably themost common endocrine disease, certainly time-consuming
and expensive, and apparently at no risk of abating. This issue of
JCTE is nominally focused on diabetes. However, the work of dia-
betes is ever-growing. So, clinically and translationally interested
endocrinologists will notice that even when “focused” on diabe-
tes, it is hard to avoid a theme of expansion.
There is a broad swath of diabetic issues covered, from basic
science and epidemiology to clinical observation. Demonstrating the
necessarily expansive nature of our approach to the epidemic of di-
abetes, articles in this issue address epidemiology, social science,
dentistry, nephrology, podiatry, nutrition, and metabolism. Dem-
onstrating the global and universal reach of diabetes, articles in this
issue come from the United States – with high representation in
ethnic and racial minorities, and internationally from Finland,
Germany, Singapore, and the Paciﬁc Islands.
Across this broad array of studies focused on diabetes, it is in-
teresting that each approach reported in this issue – epidemiological,
social, nutritional, clinical – come to strong conclusions that should
enable further study or change our clinical approach and knowl-
edge base. Epitomizing the international scope and the need to keep
an expansive open mind, a paper from Gujral, collaborating with
colleagues at Emory and the CDC in Atlanta as well as investiga-
tors from Chennai demonstrate that there is certainly more than
one “ﬂavor” to prediabetes and type 2 diabetes [1]. It is highly ac-
cepted that the pathophysiologic basis of type 2 diabetes typically
requires both insulin resistance and relative beta-cell insuﬃcien-
cy. Using data from American and South Asian databases, they
demonstrate that both groups are at very high risk for prediabetes
and diabetes, but there is a striking susceptibility to beta-cell dys-
function in the South Asian population compared to American
populations across different ethnicities, which may account for the
higher rate of diabetes in South Asians. In other words, at least two
different pathways to diabetes must be considered – one epito-
mized by early insulin resistance and the other by early beta-cell
dysfunction, though both requiring some combination of the two
to lead to eventual type 2 diabetes. One must keep an expansive
openmind to understand there are more than one pathways to type
2 diabetes.
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